As a new-type foreign trade service provider driven by both technology transformation and foreign trade services, HiSiaddi has established a "1+2+3+4=1" service system and can supply raw materials of Pueraria Mirifica extract from multiple well-known original manufacturers.
Possessing technology R&D attributes and years of on-site inspections of Pueraria Mirifica extract manufacturers, HiSiaddi maintains objective and in-depth understanding of various brands. It regularly analyzes different domestic Pueraria Mirifica extract manufacturers for clients to help them select matching products. Below is a brand selection service case.
If you require more comparative analysis of brands and models, please contact HiSiaddi customer service.
The purchaser is VitaCare GmbH based in Munich, Germany, a leading mid-to-high-end dietary supplement group in Germany with core product lines of Pueraria liver-protecting soft capsules and female endocrine conditioning oral liquids. Its full product range is sold in premium organic zones of German ROSSMANN stores, private German wellness clinics and chain health pharmacies in Austria. Raw materials comply with EU EC396 covering 226 pesticide residue items, USP Pharmacopoeia, LFGB, REACH and EUDR full-chain traceability regulations, with formulas included in Germany’s domestic catalog of natural medicinal raw materials. Annual rigid procurement volume of Pueraria Mirifica extract stands at 12.8 tons with two mandatory procurement indicators:
1. Pharmaceutical capsule powder: total isoflavones ≥40%, puerarin ≥22%, free of external starch and dextrin fillers;
2. Cold-water instant modified powder for oral liquids: fully soluble at room temperature with no precipitation or stratification after 90 days of storage at 4°C.
Previously, the client sourced European-produced Pueraria Mirifica extract from local German raw material agents for years, yet raw material quotations rose cumulatively by over 35% year after year. It launched a direct China sourcing program in 2025. Through industry exhibitions, the client independently contacted five leading domestic Pueraria Mirifica extract manufacturers: Kangmei Pharmaceutical, Shaanxi Huike, Xi’an Sinuote, Hubei GeWa and a Shandong plant extract giant for separate inquiries and sample delivery, yet fell into a selection dilemma. Each manufacturer only promoted its own full product line, following an unspoken industry norm of not belittling competitors, yet all avoided objective explanations of competitors’ strengths, weaknesses and applicable scenarios. Lacking a domestic brand database, the client could not horizontally compare specifications, processes, compliance standards and production costs across manufacturers. Testing of 12 samples from five manufacturers revealed drastically differentiated indicators and powder performance, with combined losses from sample testing and pilot wastage totaling 19,600 Euros, halting brand selection for nearly two months. The client entrusted HiSiaddi, a neutral third-party foreign trade service provider, to horizontally dissect parameters of leading domestic brands and screen matching models.
The client initially contacted five mainstream domestic mid-to-high-end plant extract brands: Kangmei Pharmaceutical (Guangdong), Shaanxi Huike, Xi’an Sinuote, Hubei GeWa Bio and Shandong Lvyuan Plant Extract. All five are benchmark domestic manufacturers of Pueraria Mirifica extract with GMP, organic and export filing qualifications and no low-grade inferior production capacity, yet their sales teams adopted identical guiding strategies: only listing their own product strengths, factory production capacity and certification qualifications while remaining silent on competitors’ technological highlights and applicable scenarios:
1. Kangmei Pharmaceutical: Mainly promotes standard national pharmacopoeia-grade 10:1 general Pueraria powder and conventional 40% total isoflavone powder, highlighting its status as a listed pharmaceutical enterprise with full industrial chains, large-scale GAP bases and full national standard testing, yet omitting Shaanxi Huike’s technological strengths in high-purity puerarin monomers and water-soluble modified powder;
2. Shaanxi Huike: Specializes in high-content 98% puerarin monomers and modified instant extracts, highlighting patented low-temperature resin refining technology yet avoiding elaboration on Kangmei’s advantages in large-batch mass production stability and complete origin traceability ledgers;
3. Xi’an Sinuote: Boasts a comprehensive product line focusing on food-grade compound raw materials and multi-specification ratio extracts with flexible small-batch customization, yet fails to objectively explain Hubei GeWa’s innate strengths in self-owned GAP wild Pueraria planting bases in Hubei;
4. Hubei GeWa Bio: Relies on self-owned Enshi GAP wild Pueraria planting gardens to produce extracts from 3-year authentic Chai Ge with high intrinsic flavonoid content, only recommending self-produced raw material extracts while avoiding mention of Sinuote’s strengths in powder modification and flexible small-batch production;
5. Shandong Lvyuan Plant Extract: Focuses on cost-effective mass bulk raw materials with sufficient spot inventory and short delivery cycles for large-volume orders, centering on bulk raw material quotations without explaining the refined customization capabilities of the other four brands for pharmaceutical-grade applications.
The client received 12 samples from five manufacturers, and testing by a German third-party laboratory revealed severe differentiation: partial samples featured puerarin fluctuations of 17%–24%, some powders failed cold-water dissolution, and individual products carried pesticide residue levels close to EU limit thresholds, unable to match differentiated raw material demands of its two production lines. The client faced a choice between mass production with all samples leading to massive wastage or finalizing suppliers relying solely on one-sided manufacturer introductions, bringing brand selection to a complete standstill.
HiSiaddi set up a task force of plant extract technical specialists and foreign trade compliance officers, leveraging domestic plant extract industry databases, on-site factory visit records and historical EU export sample testing data to neutrally dissect mainstream Pueraria Mirifica extract models, processes, applicable scenarios and pros & cons of the five brands without favoring any single manufacturer, compiling a bilingual Chinese-English comparative report item by item:
Main Model ① KM-GE01: Pharmaceutical-grade 40% total isoflavone capsule-specific refined powder meeting pharmacopoeia standards. Supported by dual GAP Pueraria bases in Guangdong and Hubei, it delivers top-tier batch stability for large-volume mass production with finished indicator fluctuations ≤±1%, complete EUDR traceability ledgers and SGS full-item pesticide residue reports. Disadvantages: No self-owned cyclodextrin modification production lines for cold-water instant oral liquid powder; modified products require outsourced processing at a higher unit price. Main Model ② KM-GE02: 10:1 food-grade general Pueraria powder suitable for low-cost solid beverages, failing to meet the client’s high-end formulation access standards. Applicable Scenarios: Large-volume procurement of pharmaceutical capsule raw materials, prioritized for the client’s soft capsule production line.
Main Model ① HK-GE40: Refined 40% total isoflavone pharmaceutical powder with stable puerarin levels of 22.3%–23%, low-temperature resin impurity removal and no external filler additives. Main Model ② HK-SOL: Water-soluble modified Pueraria Mirifica extract (core client demand), adopting patented closed low-temperature β-cyclodextrin inclusion technology enabling instant full dissolution in cold room-temperature water with crystal-clear solutions after 90 days of storage at 4°C, perfectly matching oral liquid production lines. Disadvantages: Limited self-owned Pueraria planting bases with a high proportion of externally sourced raw materials; delivery cycles for ultra-large batches (>5 tons per shipment) are 5–7 days longer than Kangmei’s. Main Model ③ HK-P98: 98% high-purity puerarin monomer mainly used as pharmaceutical API, exceeding the client’s current procurement requirements. Applicable Scenarios: Water-soluble special raw materials for oral liquids + small-batch high-end refined capsule powder.
Main Models: SNT-GE series multi-specification ratio extracts (5:1/10:1/20:1) and non-standard small-batch customized powder, featuring low minimum order quantities and flexibly adjustable formulas. Disadvantages: Weak mass production stability of pharmaceutical-grade 40% flavonoid products compared to Kangmei and Huike, prone to raw material mixing in large-volume supply; only suitable for small-batch health food production, incompatible with the client’s ton-level stable mass production.
Main Model: GW-40 wild Pueraria extract with 40% total isoflavones, entirely produced from self-owned Enshi GAP 3-year Chai Ge raw materials with high intrinsic flavonoid content and superior pesticide residue control. Disadvantages: Imperfect deep-processing modification production lines with no large-scale water-soluble powder capacity; average powder fluidity prone to filling clogging, only suitable for simple tablets, incompatible with automatic soft capsule and sterile oral liquid production lines.
Main Models: LY-10 standard domestic 10:1 general Pueraria powder and LY-40 bulk 40% flavonoid powder, featuring sufficient spot inventory and low quotations. Disadvantages: Mixed raw materials sourced from multiple producing areas leading to large fluctuations in active ingredient content, excessive solvent residue failing to meet EU pharmaceutical-grade internal control standards; only suitable for low-end food applications.
Combining the client’s dual production lines for capsules and oral liquids, strict EU compliance standards and annual stable mass production demand of 12.8 tons, HiSiaddi comprehensively evaluated four dimensions: raw material stability, process matching degree, compliance certification and delivery cycle, ultimately screening two mid-to-high-end brands (Kangmei Pharmaceutical and Shaanxi Huike) and finalizing three precisely matched models, eliminating conventional products from the other three manufacturers:
Product Parameters: Total isoflavones 40.2%–40.8%, puerarin 22.1%–22.7%, free of starch and dextrin additives, powder repose angle of 33°, compatible with automatic capsule filling. Full batches come with GAP field ledgers, SGS EC396 226-item pesticide residue reports, English COA and REACH documents to meet German drug regulatory filing requirements. Kangmei undertakes the full-year capsule raw material procurement share of 7.3 tons.
1. HK-GE40: Refined pharmaceutical powder as backup capsule raw material for small-batch emergency supplementary orders;
2. HK-SOL: Cold-water instant modified special powder, exclusively matching the client’s sterile oral liquid formula with crystal-clear solutions free of precipitation after 90 days of storage at 4°C, undertaking the full-year oral liquid procurement share of 5.5 tons.
The three finalized models fully cover all raw material demands of the client’s two production lines.
HiSiaddi coordinated the two selected manufacturers to resubmit samples complying with German standards. Full testing of the three samples by a German third-party laboratory passed all indicators, and the client conducted a consecutive 30-day pilot mass production trial in its workshop: Kangmei KM-GE01 delivered capsule filling error ≤±1.7%, slashing product rejection rate from 26% in early samples to below 1%; Huike HK-SOL produced crystal-clear oral liquid feedstock free of precipitation throughout production, passing EU 24-month shelf-life standards via accelerated stability testing. The client formally signed an annual framework procurement contract for 12.8 tons: 7.3 tons from Kangmei and 5.5 tons from Huike, split into 10 monthly batches throughout the year. The first order of 4.2 tons was shipped from Shanghai Port to Hamburg, clearing German customs in one random inspection for warehousing, allowing the new product launch delayed by two months to roll out across all premium German pharmacies and private wellness institutions. The German group later added customized procurement of organic-grade Pueraria Mirifica extract, with HiSiaddi fully coordinating sampling and comparative brand selection. Compared with its original European raw material suppliers, overall comprehensive raw material procurement costs dropped by 29.7%, and ocean transit time was shortened from 68 days to 22 days, drastically optimizing the client’s supply chain cash flow. Endorsed by this mid-to-high-end German client, Kangmei and Huike subsequently secured annual Pueraria raw material orders from two equivalent dietary supplement enterprises in the Netherlands and Belgium.
It is standard industry practice for leading domestic plant extract brands to prioritize promoting their own products and avoid objective elaboration of competitors’ strengths driven by operational interests. Mid-to-high-end European pharmaceutical enterprises specialize in terminal formulations and EU regulations yet lack familiarity with segmented positioning and differentiated technologies of domestic brands, making independent sourcing prone to biased guidance from single manufacturers and misselection of incompatible raw materials. Acting as a neutral foreign trade service provider outside manufacturers’ marketing orientations, HiSiaddi horizontally dissects advantages and disadvantages across brands leveraging its full-industry brand database, conducting precise selection based on clients’ actual production line, regulatory and formula demands. It not only helps mid-to-high-end overseas clients avoid trial-and-error losses from brand selection but also empowers high-quality domestic leading plant extract manufacturers to accurately connect with the high-end European raw material supply chain, realizing two-way precise matching between supply and demand.
If you require more comparative analysis of brands and models, please contact HiSiaddi customer service.
+86-13120989737 
info@hisiaddi.com 
English
